IL27 and myeloid sarcoma: As only the HC- and IFNb-MS-derived mDCs become tolerogenic with IL-27 treatment, the next question was to identify the genes that are similarly induced by IL-27 in HC- and IFNb-MS-derived mDCs but which are distinct from those induced in the mDCs from untreated MS patients that do not become tolerogenic.